[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624309":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":54,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Participants undergo MRI on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Non-Interventional Study","Non-interventional study",[9],[20,21],"Non-Interventional Observational Study","Noninterventional (Observational) Study",[23],{"name":24,"affiliation":25,"role":26},"Candice A. Bookwalter, MD, PhD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},"Bobbie Ott","507-293-0922",[37],{"facility":25,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-92.4699,44.02163,{"lat":48,"lon":47},[51,52,53],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},{"name":24,"role":26,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100624309","screening-and-staging-of-benign-vs-malignant-pelvic-abnormalities-100624309",false,"NCT07407959","Screening and Staging of Benign vs Malignant Pelvic Abnormalities","Clinical Evidence Generation of AI Enabled Fast, Accurate and Precise Screening and Staging of Benign vs Malignant Pelvic Abnormalities","Inclusion Criteria:\n\n* Patient over the age of 18\n* For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy\n* For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)\n\nExclusion Criteria:\n\n* Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures\u002Fconditions for scanning, pregnant people, individuals with implanted metal, etc.)\n* Patient under the age of 18\n* Patient who is unable to consent",true,"ALL","18 Years",{"count":67,"type":68},60,"ESTIMATED","OBSERVATIONAL","This study evaluates whether newly developed non-FDA approved image processing techniques \\[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\\] can provide improved quality and decreased time compared to current scanning techniques.",[72,73],"Endometrial Carcinoma","Prostate Carcinoma","2026-02-12",{"date":76,"type":77},"2026-02-17","ACTUAL",{"date":79,"type":77},"2025-09-04",{"date":81,"type":68},"2028-09-30",{"name":5,"class":6},1]